Pharmacorruption?

One third of antidepressant studies published. [Link]

A new study—"the most thorough to date," writes the New York Times—shows that about a third of the studies for some of the market's most successful antidepressants (Paxil, Prozac, Zoloft, Effexor) were never published because they didn't have favorable results. "While 94 percent of the positive studies found their way into print, just 14 percent of those with disappointing or uncertain results did." The implication is that the makers of these drugs intentionally misled consumers and the federal government on their effectiveness.

Vytorin not effective? [Link]

A clinical trial of Zetia, a popularly prescribed cholesterol-lowering drug, "failed to show that the drug has any medical benefits." In fact, fatty plaques grew almost twice as fast in patients who took Zetia along with Zocor in a combo product called Vytorin. However, "patients who are taking Vytorin or Zetia should talk to their doctors if they are concerned and not discontinue taking the medicines on their own."